Five strains of a newly described Escherichia species, Escherichia albertii, were extensively characterized by conventional biochemical methods and by commercial identification panels. E. albertii is an indole-negative species that ferments D-mannitol but not D-xylose. Because these strains are not included in the databases of commercial systems at present, they were most often identified as Hafnia, Salmonella, Escherichia coli, or, on one system (MicroScan dried overnight panels), Yersinia ruckeri.
Until recently, the genus Escherichia was composed of five species, including the type species E. coli and four less frequently encountered members: E. blattae, E. hermannii, E. vulneris, and E. fergusonii (4) . Recently, Huys and others (5) described a sixth species, E. albertii, associated with diarrheal disease in Bangladeshi children. E. albertii was originally isolated and identified by John Albert and collaborators at the International Centre for Diarrhoeal Disease Research, Bangladesh, as Hafnia alvei (1) . However, subsequent phenotypic and genetic studies conducted by several international groups clearly indicated that these strains do not belong in the genus Hafnia (6, 8, 9) . Further molecular studies including 16S ribosomal DNA sequencing and DNA-DNA pairing studies have demonstrated that these strains belong in the genus Escherichia, and a new species, E. albertii, has been proposed (5) .
Currently, only five strains of E. albertii are known to exist, and it is unclear how common this species is in clinical samples and whether all fecal strains are associated with cases of bacterial gastroenteritis. In the original description of this species (5), the biochemical properties of E. albertii were determined primarily by using the API 50 CH system (bioMérieux, Marcy l'Etoile, France), a commercial product not readily available in the United States. Because of this fact and to further characterize these strains as an aid to identification of this species, we have identified these strains in both a conventional and miniaturized commercial test format.
The five strains of E. albertii used in this study have been previously described. T ). All conventional tests were performed by using previously described procedures (7); tests conducted on MicroScan conventional overnight and rapid panels (Dade Behring MicroScan, MicroScan Inc., West Sacramento, Calif.), API 20E strips (bioMérieux, Inc., Durham, N.C.), and Vitek GNI Plus, software version R07.01 (bioMérieux, Inc.), were carried out according to the manufacturer's instructions.
Biochemical test results for all five E. albertii strains analyzed by conventional format are listed in Table 1 . These results agree with data reported by Huys et al. (5) in that E. albertii strains are nonmotile and indole negative, lysine and ornithinedecarboxylase positive, and arginine dihydrolase and VogesProskauer negative and produce acid from the fermentation of D-glucose (with gas), L-arabinose, and D-mannitol; sucrose and lactose are not fermented. All five E. albertii strains were additionally ␤-galactosidase positive. E. albertii strains also fermented D-arabinose, D-fructose, D-galactose, D-mannose, and ribose but were unable to utilize a wide variety of uncommon sugars, including D-fucose, D-lyxose, palatinose, sedoheptulose anhydride, L-sorbose, D-tagatose, D-turanose, and xylitol. Acid from glycerol was produced by all five strains only after prolonged incubation (3 to 7 days). E. albertii strains were phenotypically tight, and very few variable reactions were noted. Only fermentation of lactulose, maltose, and trehalose and esculin hydrolysis produced variable test results. Interestingly, all three strains that fermented maltose also fermented trehalose, suggesting that potential biotypes (biovars) may exist within E. albertii. No E. albertii strain produced lipase, protease, or pectinase or degraded mucate. Four of five strains produced weak to moderate L-prolineaminopeptidase activity when tested with a commercial assay (Aminopeptidase Wee-Tab; Key Scientific Products, Round Rock, Tex.).
Since E. albertii has just been described, we additionally tested these five strains on several commercial systems often used by clinical laboratories to identify gram-negative rods (Table 2) . Not surprisingly, four of the five E. albertii strains were identified as H. alvei with the API 20E strip, findings similar to those originally reported by Albert and colleagues (1) . However, all four of these strains were identified at low probabilities (45%). One strain generated a seven-digit code (5104002) that did not yield an identification. Similar to the results with API 20E, Vitek called three of these five strains H. alvei, with probability values ranging from 78 to 92%. Vitek called one strain (Albert 10790) a possible Salmonella strain (top choice), although the probability was low (70%). The type strain of E. albertii was identified as an inactive E. coli strain. In contrast, the conventional overnight panels of MicroScan called four of these five strains Yersinia ruckeri (64 to 65% probability); the remaining strain (type strain of E. albertii) was identified as E. coli (99% probability), similar to the results on Vitek. On the MicroScan rapid system, results were much more variable, with individual strains being identified as Salmonella enterica serovar Choleraesuis (two cases) and as H. alvei, E. coli O157:H7, and Citrobacter braakii/C. freundii/C. sedlakii in one instance each. Only the E. coli O157:H7 identification had high confidence (97% probability). The results of testing five E. albertii strains by conventional methods suggest that this species biochemically most closely resembles inactive E. coli, although these strains do not resemble the Alkalescens-Dispar group by virtue of their ability to produce gas from D-glucose. Unlike many active and inactive E. coli strains, E. albertii strains failed to ferment a number of sugars, including lactose, dulcitol, L-rhamnose, and melibiose. As previously noted (5), the ability to ferment D-sorbitol, a trait almost exclusively associated with E. coli among Escherichia species, clearly helps separate this group (D-sorbitol negative) from the type species of the genus. They can be biochemically distinguished from other Escherichia species by a number of tests, including failure to grow in KCN broth, the inability to utilize malonate, and the lack of acid production from D-xylose, D-arabitol, melibiose, and cellobiose. The weak to moderate L-prolineaminopeptidase activity noted in the five E. albertii strains is a useful adjunct test to separate this group from H. alvei. H. alvei strains express very strong L-prolineaminopeptidase activity in only 30 min (3); all five H. alvei strains tested produced very strongly positive reactions in 2 h. Additionally, the general pattern demonstrating the inability to ferment other carbohydrates commonly metabolized by several Escherichia species (e.g., dulcitol, salicin, raffinose, and adonitol) suggests the possible presence of E. albertii.
Because E. albertii has only recently been established, no commercial system currently includes this species in its database. Results of testing five E. albertii strains on four different systems (20 identifications) suggest that most (16 of 20, or 80%) would generate a final identification with an unacceptable probability (45 to 89%) or no identification at all. Such results should trigger a more in-depth analysis with additional tests and/or identification panels. The fact that in four of five instances E. albertii was identified as Y. ruckeri, a fish pathogen (2), on dried overnight MicroScan panels should provide an additional clue to the possible presence of E. albertii. However, some isolates (n ϭ 4) would generate acceptable (92%) to excellent (97 to 99%) identifications as either H. alvei or E. coli, and in these cases the strains would be clearly misidentified. The single best hint at present to the possible presence of E. albertii (excluding overnight MicroScan panels) seems to be an unacceptable first-choice identification of H. alvei (n ϭ 8; 50%) for an isolate that is both L-rhamnose and D-xylose negative.
The importance of E. albertii is currently unknown. Until clinical laboratories are able to identify more strains of this newly described species, the frequency, disease spectrum, and clinical significance will remain in question. A review of our extensive E. coli collection containing over 400 strains isolated over a 20-year span revealed no strains with biochemicals compatible with E. albertii.
